Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

46.01
Delayed Data
As of Sep 30
 -0.28 / -0.60%
Today’s Change
45.76
Today|||52-Week Range
66.55
-29.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$47.0B

Company Description

Teva Pharmaceutical Industries Ltd. engages in the provision of pharmaceutical services. It operates through the following two segments: Generic and Specialty Medicine. The Generic segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. The Specialty Medicine segment includes several franchises, most significantly core therapeutic areas of CNS medicines. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Contact Information

Teva Pharmaceutical Industries Ltd.
5 Basel Street
Petach Tikva Tel Aviv 49131
P:(723) 926-7267
Investor Relations:
(215) 591-8912

Employees

Shareholders

Other institutional30.41%
Mutual fund holders29.23%
Individual stakeholders--

Top Executives

Erez VigodmanPresident, Chief Executive Officer & Director
Carlo de NotaristefaniPresident & CEO-Global Operations
Eyal DeshehChief Financial Officer & Group Executive VP
Michael R. HaydenPresident-Global Research & Development
Eric DrapéExecutive Vice President & Head-Quality